Literature DB >> 19248191

Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic events.

Jennifer Y Wang1, Jonathan P Terdiman, Eric Vittinghoff, Tracy Minichiello, Madhulika G Varma.   

Abstract

AIM: To compare thromboembolism rates between hospitalized patients with a diagnosis of ulcerative colitis and other hospitalized patients at high risk for thromboembolism. To compare thromboembolism rates between patients with ulcerative colitis undergoing a colorectal operation and other patients undergoing colorectal operations.
METHODS: Data from the National Hospital Discharge Survey was used to compare thromboembolism rates between (1) hospitalized patients with a discharge diagnosis of ulcerative colitis and those with diverticulitis or acute respiratory failure, and (2) hospitalized patients with a discharge diagnosis of ulcerative colitis who underwent colectomy and those with diverticulitis or colorectal cancer who underwent colorectal operations.
RESULTS: Patients diagnosed with ulcerative colitis had similar or higher rates of combined venous thromboembolism (2.03%) than their counterparts with diverticulitis (0.76%) or respiratory failure (1.99%), despite the overall greater prevalence of thromboembolic risk factors in the latter groups. Discharged patients with colitis that were treated surgically did not have significantly different rates of venous or arterial thromboembolism than those with surgery for diverticulitis or colorectal cancer.
CONCLUSION: Patients with ulcerative colitis who do not undergo an operation during their hospitalization have similar or higher rates of thromboembolism than other medical patients who are considered to be high risk for thromboembolism.

Entities:  

Mesh:

Year:  2009        PMID: 19248191      PMCID: PMC2653404          DOI: 10.3748/wjg.15.927

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Portal vein thrombi after restorative proctocolectomy.

Authors:  Feza H Remzi; Victor W Fazio; Mustafa Oncel; Mark E Baker; James M Church; Boon S Ooi; Jason T Connor; Miriam Preen; David Einstein
Journal:  Surgery       Date:  2002-10       Impact factor: 3.982

2.  The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.

Authors:  C N Bernstein; J F Blanchard; D S Houston; A Wajda
Journal:  Thromb Haemost       Date:  2001-03       Impact factor: 5.249

3.  Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial.

Authors:  A G Turpie
Journal:  Am J Cardiol       Date:  2000-12-28       Impact factor: 2.778

4.  Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease.

Authors:  C Guédon; V Le Cam-Duchez; O Lalaude; J F Ménard; E Lerebours; J Y Borg
Journal:  Am J Gastroenterol       Date:  2001-05       Impact factor: 10.864

5.  Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis.

Authors:  J Panés; M Esteve; E Cabré; J Hinojosa; M Andreu; M Sans; F Fernandez-Bañares; F Feu; M A Gassull; J M Piqué
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

6.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.

Authors:  M M Samama
Journal:  Arch Intern Med       Date:  2000 Dec 11-25

Review 7.  Inflammation and coagulation in inflammatory bowel disease: The clot thickens.

Authors:  Silvio Danese; Alfredo Papa; Simone Saibeni; Alessandro Repici; Alberto Malesci; Maurizio Vecchi
Journal:  Am J Gastroenterol       Date:  2006-11-13       Impact factor: 10.864

8.  Venous thromboembolism according to age: the impact of an aging population.

Authors:  Paul D Stein; Russell D Hull; Fadi Kayali; William A Ghali; Andrew K Alshab; Ronald E Olson
Journal:  Arch Intern Med       Date:  2004-11-08

9.  Superior mesenteric vein thrombosis after colectomy for inflammatory bowel disease: a not uncommon cause of postoperative acute abdominal pain.

Authors:  Alessandro Fichera; Lawrence A Cicchiello; David S Mendelson; Adrian J Greenstein; Tomas M Heimann
Journal:  Dis Colon Rectum       Date:  2003-05       Impact factor: 4.585

10.  Venous thromboembolic disease: comparison of the diagnostic process in blacks and whites.

Authors:  Paul D Stein; Russell D Hull; Kalpesh C Patel; Ronald E Olson; William A Ghali; Andrew K Alshab; Frederick A Meyers
Journal:  Arch Intern Med       Date:  2003 Aug 11-25
View more
  8 in total

1.  Autoimmune diseases and venous thromboembolism: a review of the literature.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

Review 2.  Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.

Authors:  Danuta Owczarek; Dorota Cibor; Mikołaj K Głowacki; Tomasz Rodacki; Tomasz Mach
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

3.  The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active ulcerative colitis.

Authors:  J L Pleet; B P Vaughn; J A Morris; A C Moss; A S Cheifetz
Journal:  Aliment Pharmacol Ther       Date:  2014-03-10       Impact factor: 8.171

4.  Clinical characteristics and risk factors predictive of pulmonary embolism complicated in bronchiectasis patients: a retrospective study.

Authors:  Tiantian Deng; Ke Xu; Beishou Wu; Fei Sheng; Xu Li; Zhuxian Zhu; Ziqiang Zhang
Journal:  BMC Pulm Med       Date:  2022-06-09       Impact factor: 3.320

5.  Increased risk of stroke among patients with ulcerative colitis: a population-based matched cohort study.

Authors:  Joseph J Keller; Jui Wang; Ya-Li Huang; Chia-Chi Chou; Li-Hsuan Wang; Jung-Lung Hsu; Chyi-Huey Bai; Hung-Yi Chiou
Journal:  Int J Colorectal Dis       Date:  2014-04-17       Impact factor: 2.571

6.  Hospitalizations of adults ≥60 years of age with venous thromboembolism.

Authors:  Hussain R Yusuf; Nimia Reyes; Qing C Zhang; Ekwutosi M Okoroh; Azfar-E-Alam Siddiqi; James Tsai
Journal:  Clin Appl Thromb Hemost       Date:  2013-06-27       Impact factor: 2.389

7.  Combined portal, splenic and mesenteric venous thrombosis in inactive ulcerative colitis with heterozygous mutation in MTHFR gene: A rare case of thrombophilia.

Authors:  Gül Gürsoy; Ahmet Cimbek; Yaşar Acar; Birsen Erol; Hayriye Cankar Dal; Nuray Evrin; Aslı Gungor
Journal:  J Res Med Sci       Date:  2011-11       Impact factor: 1.852

8.  Preoperative prevalence and risk factors of deep-vein thrombosis in Japanese surgical patients with ulcerative colitis: a retrospective investigational study.

Authors:  Hiroki Ohya; Hideaki Kimura; Jun Watanabe; Kazuya Nakagawa; Yusuke Suwa; Mayumi Ozawa; Atsushi Ishibe; Reiko Kunisaki; Chikara Kunisaki; Itaru Endo
Journal:  Surg Today       Date:  2021-07-08       Impact factor: 2.549

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.